Threat imminence dictates the role of the bed nucleus of the stria terminalis in contextual fear.


Journal

Neurobiology of learning and memory
ISSN: 1095-9564
Titre abrégé: Neurobiol Learn Mem
Pays: United States
ID NLM: 9508166

Informations de publication

Date de publication:
01 2020
Historique:
received: 11 08 2019
revised: 09 11 2019
accepted: 13 11 2019
pubmed: 20 11 2019
medline: 23 1 2021
entrez: 20 11 2019
Statut: ppublish

Résumé

Recent work indicates that the bed nucleus of the stria terminalis (BNST) is critically involved in the regulation of conditioned fear responses to unpredictable threats. Here we examined whether the involvement of the BNST in contextual fear conditioning in male rats depends on the imminence of shock after placement in the conditioning chamber. Specifically, we hypothesized that the BNST supports contextual freezing after conditioning with delayed, but not imminent, footshock (relative to placement in the context). Rats were implanted with cannulae targeting the BNST and underwent a contextual fear conditioning procedure in which a single footshock unconditioned stimulus (US) was delivered either 1 min or 9 min after the rat was placed in the context; the rats received a total of four identical conditioning sessions over two days, all with equivalent exposure to the context. Contexts associated with either imminent or delayed US onsets produced distinct patterns of freezing and shock-induced activity but freezing in each case was context-dependent. Reversible inactivation of the BNST reduced the expression of contextual freezing in the context paired with delayed (9 min), but not imminent (1 min), footshock onset. Implications of these data are discussed in the light of recent conceptualizations of BNST function, as well as for anxiety behaviors.

Identifiants

pubmed: 31740383
pii: S1074-7427(19)30183-2
doi: 10.1016/j.nlm.2019.107116
pmc: PMC6980749
mid: NIHMS1545313
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

107116

Subventions

Organisme : NIMH NIH HHS
ID : F31 MH107113
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH065961
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH117852
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Références

Neuropsychopharmacology. 2016 Jan;41(1):335-56
pubmed: 25976297
Neurosci Biobehav Rev. 2016 Sep;68:177-194
pubmed: 27216212
Mol Cells. 2015 Jan 31;38(1):1-13
pubmed: 25475545
Psychopharmacology (Berl). 2011 Jan;213(1):19-27
pubmed: 20827461
ACS Chem Neurosci. 2019 Jul 17;10(7):3154-3166
pubmed: 31140276
Transl Psychiatry. 2017 Feb 14;7(2):e1033
pubmed: 28195571
Neuropsychol Rev. 2019 Jun;29(2):181-185
pubmed: 30229440
Front Neurosci. 2015 Sep 09;9:321
pubmed: 26441496
Behav Neurosci. 2006 Apr;120(2):324-36
pubmed: 16719697
Dialogues Clin Neurosci. 2015 Sep;17(3):261-79
pubmed: 26487807
Behav Brain Res. 2009 Mar 2;198(1):69-73
pubmed: 19000716
Transl Psychiatry. 2019 Apr 18;9(1):140
pubmed: 31000694
Nature. 2016 Sep 1;537(7618):97-101
pubmed: 27556938
Neurobiol Learn Mem. 2001 Nov;76(3):268-83
pubmed: 11726237
Neuropharmacology. 2014 Jan;76 Pt B:320-8
pubmed: 23752096
Front Behav Neurosci. 2014 Apr 01;8:112
pubmed: 24744710
Neuroscience. 2004;128(1):7-14
pubmed: 15450349
Learn Mem. 2015 Aug 18;22(9):417-25
pubmed: 26286652
Neurosci Lett. 2019 Feb 6;693:58-67
pubmed: 29195911
Neurobiol Learn Mem. 2011 Feb;95(2):199-205
pubmed: 21073972
Nat Rev Neurosci. 2013 Jun;14(6):417-28
pubmed: 23635870
Nat Neurosci. 2015 Oct;18(10):1394-404
pubmed: 26404714
J Affect Disord. 2018 Mar 1;228:248-253
pubmed: 29304469
Eur J Pharmacol. 2003 Feb 28;463(1-3):199-216
pubmed: 12600711
Front Psychiatry. 2019 Jul 17;10:510
pubmed: 31379626
J Mol Neurosci. 2019 Jul;68(3):453-464
pubmed: 30074172
Ann N Y Acad Sci. 1997 Jun 21;821:305-31
pubmed: 9238214
J Neurosci. 1988 Jul;8(7):2517-29
pubmed: 2854842
J Trauma Stress. 2014 Oct;27(5):602-9
pubmed: 25322889
Psychoneuroendocrinology. 2018 Mar;89:239-249
pubmed: 29395488
ACS Chem Neurosci. 2018 Sep 19;9(9):2173-2187
pubmed: 29851347
Mol Psychiatry. 2017 Oct;22(10):1422-1430
pubmed: 27698427
Philos Trans R Soc Lond B Biol Sci. 1997 Nov 29;352(1362):1675-87
pubmed: 9415919
J Cogn Neurosci. 2019 Apr;31(4):543-559
pubmed: 30605004
Alcohol. 2012 Jun;46(4):303-8
pubmed: 22449787
Neuropharmacology. 2013 Jul;70:324-30
pubmed: 23466330
Prog Neuropsychopharmacol Biol Psychiatry. 2009 Nov 13;33(8):1291-308
pubmed: 19595731
eNeuro. 2015 Jul 03;2(3):
pubmed: 26464990
Mol Psychiatry. 2016 Apr;21(4):450-63
pubmed: 26878891
Neuropsychopharmacology. 2016 Jan;41(1):126-41
pubmed: 26105138
Behav Brain Res. 2011 Sep 23;222(2):357-62
pubmed: 21497171
J Neurosci. 1997 Aug 15;17(16):6434-46
pubmed: 9236251
Neuroimage. 2014 May 1;91:311-23
pubmed: 24444996
Nature. 2013 Apr 11;496(7444):224-8
pubmed: 23515155
J Clin Psychiatry. 2010 Jul;71(7):839-54
pubmed: 20667290
Neuroimage Clin. 2019;22:101735
pubmed: 30878610
Pharmacol Biochem Behav. 2002 Mar;71(3):379-92
pubmed: 11830172
Front Behav Neurosci. 2019 Apr 05;13:68
pubmed: 31024271
Neurobiol Learn Mem. 2016 May;131:137-46
pubmed: 27038742
Nat Rev Dis Primers. 2017 May 04;3:17024
pubmed: 28470168
Brain Struct Funct. 2018 May;223(4):1839-1848
pubmed: 29249047
Neuropsychopharmacology. 2010 Jan;35(1):105-35
pubmed: 19693004
Brain Struct Funct. 2014 Nov;219(6):1969-82
pubmed: 23934654
J Neurosci. 2016 Aug 3;36(31):8038-49
pubmed: 27488624
J Psychopharmacol. 2017 Jun;31(6):674-681
pubmed: 28198211
Behav Neurosci. 2015 Oct;129(5):673-8
pubmed: 26348716
Horm Behav. 2015 Nov;76:136-42
pubmed: 25888455
Learn Mem. 2013 Oct 16;20(11):633-41
pubmed: 24131794
Horm Behav. 2017 Mar;89:137-144
pubmed: 28104355
Psychopharmacology (Berl). 2019 Jan;236(1):415-437
pubmed: 30255379
Neuropharmacology. 2012 Feb;62(2):565-75
pubmed: 21396383
Front Behav Neurosci. 2015 Aug 04;9:205
pubmed: 26300750
Neuropsychopharmacology. 2016 Jan;41(1):103-25
pubmed: 26096838
Biol Psychiatry. 2015 Sep 1;78(5):336-43
pubmed: 25981173
J Comp Physiol Psychol. 1968 Aug;66(1):1-5
pubmed: 5672628
J Neurosci. 1998 Apr 15;18(8):3088-97
pubmed: 9526025
Prog Neuropsychopharmacol Biol Psychiatry. 2009 Nov 13;33(8):1309-20
pubmed: 19467288
Behav Processes. 2019 Sep;166:103890
pubmed: 31254627
Neuroscience. 2008 Jun 26;154(3):869-76
pubmed: 18479825
Dialogues Clin Neurosci. 2017 Jun;19(2):127-136
pubmed: 28867937
Psychon Bull Rev. 1994 Dec;1(4):429-38
pubmed: 24203551
J Neurol Neurosurg Psychiatry. 2019 Dec;90(12):1353-1360
pubmed: 31256001
J Neurosci. 2016 Aug 3;36(31):8050-63
pubmed: 27488625
Prog Neuropsychopharmacol Biol Psychiatry. 2018 Dec 20;87(Pt A):108-125
pubmed: 29330137
Am Psychol. 1988 Mar;43(3):151-60
pubmed: 3364852
Elife. 2019 Apr 04;8:
pubmed: 30946011
Neuroscience. 2012 Sep 27;221:21-7
pubmed: 22766237
Trends Neurosci. 2015 May;38(5):319-29
pubmed: 25851307
Nature. 2015 Jan 15;517(7534):284-92
pubmed: 25592533
Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14881-6
pubmed: 20679237
J Psychopharmacol. 2008 Aug;22(6):633-41
pubmed: 18308797
Curr Opin Behav Sci. 2018 Dec;24:44-49
pubmed: 30276224
J Neurosci. 2009 Aug 19;29(33):10357-61
pubmed: 19692610
Nat Rev Neurosci. 2018 Sep;19(9):535-551
pubmed: 30054570
Neuropharmacology. 2017 Aug 1;122:100-106
pubmed: 28351600
Annu Rev Neurosci. 2001;24:897-931
pubmed: 11520922
J Neurosci. 2003 Jan 1;23(1):23-8
pubmed: 12514197
Curr Neuropharmacol. 2013 Mar;11(2):141-59
pubmed: 23997750
Depress Anxiety. 2019 Aug;36(8):666-675
pubmed: 30953446
J Trauma Stress. 2013 Oct;26(5):537-47
pubmed: 24151000
Behav Neurosci. 2005 Dec;119(6):1459-66
pubmed: 16420150
Neuropharmacology. 2015 Dec;99:627-38
pubmed: 26302652
Learn Mem. 2017 Aug 16;24(9):480-491
pubmed: 28814474
J Mol Neurosci. 2010 Nov;42(3):327-40
pubmed: 20405238
Neuropsychol Rev. 2019 Jun;29(2):186-189
pubmed: 30888605
J Neurosci. 1997 Dec 1;17(23):9375-83
pubmed: 9364083
Neuropharmacology. 2017 Jul 15;121:130-139
pubmed: 28456687
Brain Struct Funct. 2008 Sep;213(1-2):29-42
pubmed: 18528706

Auteurs

Travis D Goode (TD)

Department of Psychological and Brain Sciences and Institute for Neuroscience, Texas A&M University, College Station, TX 77843-3474, USA.

Gillian M Acca (GM)

Department of Psychological and Brain Sciences and Institute for Neuroscience, Texas A&M University, College Station, TX 77843-3474, USA.

Stephen Maren (S)

Department of Psychological and Brain Sciences and Institute for Neuroscience, Texas A&M University, College Station, TX 77843-3474, USA. Electronic address: maren@tamu.edu.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH